Skip to main content
. 2023 Jun 7;78(6):1698–1710. doi: 10.1097/HEP.0000000000000502

FIGURE 2.

FIGURE 2

Kaplan-Meier estimates of overall 6-year outcomes in children with Alagille syndrome treated with maralixibat. (A) EFS. (B) TFS. The dashed line indicates a 75% survival threshold. The shaded area indicates 95% confidence limits. Abbreviations: EFS, event-free survival; TFS, transplant-free survival.